http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112012000204-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e927b9dcadf648b7f8aa11c29aa33536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d90020ad1e3b42157420eabd0701297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e68f5df8b9842356701c0522dc9933ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c913b61ddbf004bc9b42b03a24ae611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28eb0330d7e039741fa65ab69653deda
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
filingDate 2010-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58ca254c2eb1db107e8a3772897da6df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5148bdd49ce1def790e5d5f065b416f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e3e1675cfd3b7c4f476b186a08b9fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c288a4fbc9ea6bf102541c8a3e9c240a
publicationDate 2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112012000204-A8
titleOfInvention PHARMACEUTICAL COMPOSITION IN UNIT DOSAGE FORM INCLUDING APOMORPHINE AND ITS USE
abstract PHARMACEUTICAL COMPOSITION IN UNIT DOSAGE FORM COMPRISING APOMORPHINE AND ITS USE. The present invention relates to sublingual formulations of apomorphine and apomorphine prodrugs, and methods of treating Parkinson's disease, sexual dysfunction, and depressive disorders therewith.
priorityDate 2009-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005

Total number of triples: 39.